ZTOX

SPML Infra (SPMLINFRA): Investor Presentation

Investor Presentation SPML Infra Limited has informed the Exchange about Investor Presentation SPML Infra Limited has informed the Exchange about Investor Presentation

SPML Infra (SPMLINFRA): Company Update

Company Update Investor presentation for Quarter $ and year ended 31st march 2026 Investor presentation for Quarter $ and year ended 31st march 2026

SPML Infra (SPMLINFRA): Outcome of Board Meeting

Outcome of Board Meeting SPML Infra Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026. SPML Infra Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.

SPML Infra (SPMLINFRA): Outcome of Board Meeting

SPML

Speciality Medicines Files FY26 Results on BSE

Speciality Medicines (SPML) has submitted its financial results for the half year and fiscal year ending March 31, 2026 on the BSE platform.

SPML

Speciality Medicines Submits FY2026 Annual Results to BSE

Speciality Medicines has submitted its H2 and FY2026 financial results to BSE for the period ending March 31, 2026.

Market Updates Earnings conference call

SPML Infra Files Transcript: Key Insights from Latest Earnings Call

SPML Infra Limited has filed its latest earnings call transcript with the NSE following an analysts and institutional investor meet. Visit ztox.in for the full breakdown.

Market Updates Earnings conference call

SPML Infra Q4 FY26 Earnings Call Transcript Now Available

SPML Infra Q4 FY26 earnings call transcript released for the quarter ending March 31 2026. The conference call covered company performance and outlook.